COSETTE Company Profile

✉ Email this page to a colleague

COSETTE has one hundred and eighteen approved drugs.

There are five US patents protecting COSETTE drugs.

There are seventy-six patent family members on COSETTE drugs in twenty-six countries and ninety-one supplementary protection certificates in fourteen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cosette	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	OINTMENT;TOPICAL	089524-001	Jul 26, 1988	AT	RX	No	No		⤷ Sign Up				⤷ Sign Up
Cosette	CLOMIPHENE CITRATE	clomiphene citrate	TABLET;ORAL	075528-001	Aug 30, 1999		RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Cosette	TRUPHYLLINE	aminophylline	SUPPOSITORY;RECTAL	085498-002	Jan 3, 1983		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cosette	WELCHOL	colesevelam hydrochloride	FOR SUSPENSION;ORAL	022362-002	Oct 2, 2009	5,919,832*PED	⤷ Sign Up
Cosette	BENICAR	olmesartan medoxomil	TABLET;ORAL	021286-004	Apr 25, 2002	6,878,703*PED	⤷ Sign Up
Cosette	TRIBENZOR	amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	200175-005	Jul 23, 2010	5,616,599*PED	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	10 mg/20 mg and 5 mg/40 mg	➤ Subscribe	2008-03-31
➤ Subscribe	Tablets	20 mg/12.5 mg	➤ Subscribe	2007-05-11
➤ Subscribe	Tablets	5 mg and 10 mg	➤ Subscribe	2013-07-10
➤ Subscribe	Powder for Oral Suspension	1.875 g/Packet and 3.75 g/Packet	➤ Subscribe	2010-04-09
➤ Subscribe	Tablets	5 mg/20 mg and 10 mg/40 mg	➤ Subscribe	2008-02-11
➤ Subscribe	Tablets	5 mg, 20 mg and 40 mg	➤ Subscribe	2006-04-25
➤ Subscribe	Tablets	40 mg/12.5 mg and 40 mg/25 mL	➤ Subscribe	2007-02-15
➤ Subscribe	Tablets	625 mg	➤ Subscribe	2009-07-01
➤ Subscribe	Capsules	30 mg	➤ Subscribe	2009-02-27

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	03006620	⤷ Sign Up
Eurasian Patent Organization	032959	⤷ Sign Up
Israel	180419	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1915993	300625	Netherlands	⤷ Sign Up	PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414
0443983	C00443983/03	Switzerland	⤷ Sign Up	PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009
2233112	132014902285293	Italy	⤷ Sign Up	PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.